{"organizations": [], "uuid": "426b84eb5f347c65dc37d0725c3f5353de042f8a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-bellicum-pharmaceuticals-announces/brief-bellicum-pharmaceuticals-announces-pricing-of-public-offering-of-common-stock-idUSASC09W87", "country": "US", "domain_rank": 408, "title": "BRIEF-Bellicum Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-18T04:24:00.000+03:00", "replies_count": 0, "uuid": "426b84eb5f347c65dc37d0725c3f5353de042f8a"}, "author": "", "url": "https://www.reuters.com/article/brief-bellicum-pharmaceuticals-announces/brief-bellicum-pharmaceuticals-announces-pricing-of-public-offering-of-common-stock-idUSASC09W87", "ord_in_thread": 0, "title": "BRIEF-Bellicum Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-bellicum pharmaceuticals announces pricing of public offering of common stock", "sentiment": "negative"}, {"name": "public offering of common stock reuters", "sentiment": "none"}, {"name": "bellicum pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 17 (Reuters) - Bellicum Pharmaceuticals Inc:\n* BELLICUM PHARMACEUTICALS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK\n* SAYS PUBLIC OFFERING OF 8.00 MILLION COMMON SHARES PRICED AT $7.50PER SHARE Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-04-18T04:24:00.000+03:00", "crawled": "2018-04-18T04:47:34.008+03:00", "highlightTitle": ""}